Takeda moves to full independence in China as new commercial ops set up
This article was originally published in Scrip
Executive Summary
Takeda has formally established its first fully independent sales and marketing operation in China, positioning Japan's largest drugs firm for an expanded presence in this key market amid patent expiry challenges to its top products in the US.